<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-28584" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Riehl Melanosis</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Daadaa</surname>
            <given-names>Najla</given-names>
          </name>
          <aff>Military Hospital of Tunis</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sathe</surname>
            <given-names>Nishad C.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ben Tanfous</surname>
            <given-names>Azima</given-names>
          </name>
          <aff>Habib Thameur Hospital</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Najla Daadaa declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Nishad Sathe declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Azima Ben Tanfous declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>4</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-28584.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Riehl melanosis is an acquired pigmentary disorder that predominantly affects darker-skinned individuals, particularly older women. This condition is characterized by brown-gray reticulated-to-diffuse hyperpigmented macules or patches on the face, neck, and upper chest. Riehl melanosis is believed to result from a type IV hypersensitivity reaction triggered by contact allergens such as personal fragrances, textiles, and cosmetics. However, genetic factors, autoimmune conditions, and UV light exposure may also contribute to the condition's development.&#x000a0;Management involves allergen avoidance, sun protection, and various tailored topical, oral, and procedural therapies to meet individual patient needs. Regular monitoring using the dermal pigmentation area and severity index (DPASI) is necessary to gauge treatment efficacy and mitigate potential psychosocial impacts.</p>
        <p>Despite the distinctive clinical presentation of Riehl melanosis, a thorough evaluation is necessary for its differential diagnosis, including skin biopsy, dermoscopy, and reflectance confocal microscopy. This is crucial to differentiate it from similar conditions within the spectrum of acquired dermal macular hyperpigmentation, such as erythema dyschromicum perstans and lichen planus pigmentosus. Although pigmented contact dermatitis bears similarities to Riehl melanosis, the extent of inflammation observed creates the distinctions between them.&#x000a0;A definitive treatment or cure for Riehl melanosis remains elusive, and outcomes may vary depending on the chosen modality.&#x000a0;This activity provides healthcare professionals with the necessary knowledge and tools to accurately diagnose, effectively manage, and prevent adverse effects of the condition, ultimately enhancing patient outcomes and quality of life.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the clinical manifestations and characteristic features of Riehl melanosis.</p></list-item><list-item><p>Screen patients presenting with hyperpigmented macules or patches for potential Riehl melanosis&#x000a0;through accurate diagnostic techniques.</p></list-item><list-item><p>Select the most suitable treatment modalities based on patient preference, disease severity, and comorbidities.</p></list-item><list-item><p>Collaborate with other healthcare professionals to optimize patient care and treatment outcomes, ensuring effective management and addressing any complications or relapses promptly and effectively.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28584&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28584">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-28584.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Riehl melanosis is an acquired pigmentary disorder that predominantly affects darker-skinned individuals, particularly older women. This condition is characterized by brown-gray reticulated-to-diffuse hyperpigmented macules or patches on the face, neck, and upper chest&#x000a0;(see <bold>Image.</bold>&#x000a0;Clinical Photographs of Riehl Melanosis).<xref ref-type="bibr" rid="article-28584.r1">[1]</xref>&#x000a0;The&#x000a0;etiology is presumed to be a type IV&#x000a0;hypersensitivity reaction triggered by contact allergens such as personal fragrances, textiles, and cosmetics. However, genetic factors, autoimmune conditions, and UV light exposure may also contribute to the condition's development.<xref ref-type="bibr" rid="article-28584.r2">[2]</xref></p>
        <p>Despite the distinctive clinical presentation of Riehl melanosis, a thorough evaluation is necessary for its differential diagnosis, which may involve various techniques such as skin biopsy, patch testing, dermoscopy, reflectance confocal microscopy, or newer diagnostic tools following an initial clinical examination of the patients. These tools are crucial for diagnosing and distinguishing Riehl melanosis from other differential diagnoses, including conditions such as lichen planus pigmentosus and erythema dyschromicum perstans, all falling under the spectrum of acquired dermal macular hyperpigmentation. Histopathological examination of a skin biopsy will reveal basal layer vacuolar degeneration accompanied by colloid bodies and pigment incontinence.<xref ref-type="bibr" rid="article-28584.r3">[3]</xref>&#x000a0;</p>
        <p>Apart from allergen avoidance, management of this condition involves sun protection and various tailored&#x000a0;regular skincare measures. Treatment options include topical therapies (such as hydroquinone, azelaic acid, and retinoids), oral therapies (such as tranexamic acid, glycyrrhizin, and mycophenolate mofetil), chemical peels (such as salicylic acid and glycolic acid), and lasers and light therapy (such as 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser and intense pulsed light) to meet individual patient needs.<xref ref-type="bibr" rid="article-28584.r4">[4]</xref> Regular monitoring using the dermal pigmentation area and severity index (DPASI) is necessary to gauge treatment efficacy and mitigate potential psychosocial impacts. This involves ensuring regular observation for improvement of hyperpigmentation, which can have deleterious effects if left untreated, particularly in patients with Riehl melanosis.<xref ref-type="bibr" rid="article-28584.r5">[5]</xref></p>
        <p>Riehl melanosis was first&#x000a0;described by Gustav Riehl in 1917, who observed striking rough, indurated brown-gray&#x000a0;pigmentation on the forehead, temporal, and zygomatic regions on patients' faces (see <bold>Image.</bold> Riehl Melanosis on the Left Cheek).<xref ref-type="bibr" rid="article-28584.r6">[6]</xref>&#x000a0;Initially, it was believed to be related to nutritional substitutions resulting from wartime food measures, such as poor-quality flour. However, it later became evident that it was also present on the faces of women who used cosmetic products.<xref ref-type="bibr" rid="article-28584.r6">[6]</xref><xref ref-type="bibr" rid="article-28584.r7">[7]</xref> Consequently, the condition transitioned from being termed war dermatosis to melanosis faciei feminae, eventually becoming known simply as Riehl melanosis.<xref ref-type="bibr" rid="article-28584.r1">[1]</xref>&#x000a0;</p>
        <p>Riehl melanosis&#x000a0;belongs to a group of conditions collectively referred to as acquired dermal macular hyperpigmentation (previously known as macular pigmentation of uncertain etiology). This group may encompass Riehl melanosis, erythema dyschromicum perstans, lichen planus pigmentosus, melasma, exogenous ochronosis, idiopathic macular eruptive pigmentation, and pigmented contact dermatitis.<xref ref-type="bibr" rid="article-28584.r2">[2]</xref><xref ref-type="bibr" rid="article-28584.r8">[8]</xref>&#x000a0;The acquired dermal macular pigmentation disorders have similar clinical and histopathological findings.<xref ref-type="bibr" rid="article-28584.r9">[9]</xref>&#x000a0;</p>
        <p>Pigmented contact dermatitis&#x000a0;is considered a variant of Riehl melanosis, with an identified contact allergen, such as cosmetics like kumkum (see <bold>Image.</bold>&#x000a0;Kumkum-Induced Pigmented Contact Dermatitis).<xref ref-type="bibr" rid="article-28584.r9">[9]</xref> Although pigmented contact dermatitis shares similarities with Riehl melanosis, the extent of inflammation observed creates distinctions between them. Some experts consider pigmented contact dermatitis and Riehl melanosis identical; however, this view may be controversial, as pigmented contact dermatitis typically exhibits minimal to no inflammation compared to Riehl melanosis. Thus, this group of conditions may be classified as acquired dermal macular pigmentation with or without contact sensitization.<xref ref-type="bibr" rid="article-28584.r1">[1]</xref>&#x000a0;Please see StatPearls' companion resource, "<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/point-of-care/20379">Contact Dermatitis</ext-link>," for further information.&#x000a0;</p>
      </sec>
      <sec id="article-28584.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of Riehl melanosis is unknown, but many intrinsic and extrinsic factors have been proposed.<xref ref-type="bibr" rid="article-28584.r1">[1]</xref>&#x000a0;These factors include genetic predisposition to Riehl melanosis, predilection for autoimmune conditions, type IV hypersensitivity reactions, and UV light exposure.<xref ref-type="bibr" rid="article-28584.r10">[10]</xref><xref ref-type="bibr" rid="article-28584.r11">[11]</xref><xref ref-type="bibr" rid="article-28584.r12">[12]</xref><xref ref-type="bibr" rid="article-28584.r13">[13]</xref><xref ref-type="bibr" rid="article-28584.r14">[14]</xref>&#x000a0;</p>
        <p>
<bold>Etiopathogenesis of&#x000a0;Riehl Melanosis</bold>
</p>
        <p>Although not all features must be present for Riehl melanosis, the below-mentioned&#x000a0;factors may contribute to&#x000a0;its etiopathogenesis.</p>
        <p><bold>Type IV hypersensitivity reaction:</bold>&#x000a0;Riehl melanosis typically arises in areas of fragrance or cosmetic product application, suggesting allergic contact dermatitis as its primary cause.<xref ref-type="bibr" rid="article-28584.r1">[1]</xref>&#x000a0;The presence of basal cell liquefaction and degeneration on reflectance confocal microscopy implies a chronic inflammatory state&#x000a0;that may surpass&#x000a0;the more commonly encountered&#x000a0;contact dermatitis.<xref ref-type="bibr" rid="article-28584.r15">[15]</xref>&#x000a0;Inflammatory changes are believed to disturb melanin synthesis, distribution, and degradation, resulting in dispersed melanin granules within the superficial dermis, which are subsequently phagocytosed by melanophages, leading to pigment incontinence on histopathology.<xref ref-type="bibr" rid="article-28584.r3">[3]</xref>&#x000a0;This reaction is associated with a stratum basale cytolytic reaction rather than an eczematous stratum spinosum reaction.<xref ref-type="bibr" rid="article-28584.r7">[7]</xref>&#x000a0;</p>
        <p><bold>Genetic&#x000a0;factors:</bold>&#x000a0;Elevated guanine deaminase function is observed in patients with Riehl melanosis, correlating with upregulation of stem cell factor, endothelin-1, c-kit gene products, and estrogen and progesterone receptors.<xref ref-type="bibr" rid="article-28584.r11">[11]</xref> Next-generation sequencing has identified increased guanine deaminase function in Riehl melanosis, potentially predisposing individuals to basement membrane or keratinocyte damage.<xref ref-type="bibr" rid="article-28584.r16">[16]</xref></p>
        <p><bold>Autoimmune association:</bold> The significant correlation between Riehl melanosis and concurrent autoimmune conditions suggests a potential autoimmune association with Riehl melanosis. Riehl melanosis has been associated with Sj&#x000f6;gren syndrome, AIDS,&#x000a0;systemic lupus erythematosus,&#x000a0;and thyroid disease.<xref ref-type="bibr" rid="article-28584.r10">[10]</xref><xref ref-type="bibr" rid="article-28584.r1">[1]</xref>&#x000a0;Riehl melanosis has also been associated with anti-SSA (anti-Ro) antibodies. Notably, it has been postulated that these antibodies on keratinocytes destabilize the extracellular matrix and predispose patients to immune dysregulation.<xref ref-type="bibr" rid="article-28584.r17">[17]</xref><xref ref-type="bibr" rid="article-28584.r1">[1]</xref><xref ref-type="bibr" rid="article-28584.r18">[18]</xref>&#x000a0;Additionally, Riehl melanosis may exhibit immune dysregulation through alterations in human leukocyte antigen (HLA), particularly in HLA-A2, HLA-DPA1, and HLA-DPB1. Other proposed pathways include the activation of T-cells with CD8 and CD45RO markers, adrenocorticotropin-related hormone, or melanocortin-1 receptor (MC1R).<xref ref-type="bibr" rid="article-28584.r1">[1]</xref><xref ref-type="bibr" rid="article-28584.r18">[18]</xref></p>
        <p><bold>UV light exposure:</bold>&#x000a0;The photodistributed presentation of Riehl melanosis has led to speculation about its relationship with the etiopathogenesis of the condition. It is suggested that it may be associated with photosensitization of allergens, as photopatch testing has been observed to replicate pigmented reactions similar to Riehl melanosis.<xref ref-type="bibr" rid="article-28584.r10">[10]</xref><xref ref-type="bibr" rid="article-28584.r19">[19]</xref> UV light exposure may activate dermal fibroblast CCN1 protein, which in turn induces melanogenesis by binding to integrin &#x003b1;6&#x003b2;1, p38 mitogen-activated protein kinase, and extracellular signal-regulated kinases (ERK) 1 and 2. These signaling cascades activate microphthalmia-associated transcription factor (MITF), tyrosinase, and tyrosinase-related protein-1 (TRP-1).<xref ref-type="bibr" rid="article-28584.r1">[1]</xref><xref ref-type="bibr" rid="article-28584.r12">[12]</xref></p>
        <p>Several contact allergens, including airborne allergens, have&#x000a0;been associated with Riehl melanosis and are listed in the table below (see <bold>Table</bold>).<xref ref-type="bibr" rid="article-28584.r20">[20]</xref><xref ref-type="bibr" rid="article-28584.r21">[21]</xref><xref ref-type="bibr" rid="article-28584.r7">[7]</xref><xref ref-type="bibr" rid="article-28584.r22">[22]</xref>&#x000a0;Additional allergens,&#x000a0;including medications (such as minoxidil 5%) and endogenous factors (such as digestive disorders), have also been implicated.<xref ref-type="bibr" rid="article-28584.r22">[22]</xref><xref ref-type="bibr" rid="article-28584.r6">[6]</xref><xref ref-type="bibr" rid="article-28584.r23">[23]</xref></p>
        <table-wrap id="article-28584.table0" position="float" orientation="portrait">
          <caption>
            <title>Table. Commons Allergens in Riehl Melanosis</title>
          </caption>
          <table style="width: 800px;" border="1" cellspacing="1" cellpadding="10">
            <tbody>
              <tr style="height: 26px;">
                <td style="height: 26px; width: 130.637px;" rowspan="1" colspan="1">
<bold>Sources of Allergens</bold>
</td>
                <td style="height: 26px; width: 618.363px;" rowspan="1" colspan="1">
<bold>Common Allergens</bold>
</td>
              </tr>
              <tr style="height: 155px;">
                <td style="height: 155px; width: 130.637px;" rowspan="1" colspan="1">Cosmetics</td>
                <td style="height: 155px; width: 618.363px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Aniline dyes&#x000a0;</p></list-item><list-item><p>Red and yellow pigments</p></list-item><list-item><p>Brilliant Lake Red R (widely used in cheek rouges and lipsticks until 1976)&#x000a0;<xref ref-type="bibr" rid="article-28584.r24">[24]</xref></p></list-item><list-item><p>Chromium hydroxide (pigment)</p></list-item><list-item><p>Carbanilides (photosensitizer and bactericidal agent)</p></list-item><list-item><p>Ricinoleic acid (bactericidal agent)</p></list-item><list-item><p>Hair dyes (most commonly from paraphenylenediamine)</p></list-item><list-item><p>Henna (usually due to paraphenylenediamine)&#x000a0;<xref ref-type="bibr" rid="article-28584.r13">[13]</xref></p></list-item><list-item><p>Kumkum&#x02014;a red powder used on the forehead of women in India as a cultural symbol of&#x000a0;marital status</p></list-item></list>
</td>
              </tr>
              <tr style="height: 128px;">
                <td style="height: 128px; width: 130.637px;" rowspan="1" colspan="1">Fragrance</td>
                <td style="height: 128px; width: 618.363px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Geraniol oil</p></list-item><list-item><p>Lemon oil (photosensitizer)</p></list-item><list-item><p>Musk Ambrette (photosensitizer&#x000a0;and airborne allergen)</p></list-item><list-item><p>Hydroxycitronellal</p></list-item><list-item><p>Benzyl salicylate</p></list-item><list-item><p>Ylang-ylang oil</p></list-item><list-item><p>Jasmine absolute</p></list-item><list-item><p>Lavender oil</p></list-item><list-item><p>Chromates (as in soap)</p></list-item></list>
</td>
              </tr>
              <tr style="height: 115px;">
                <td style="height: 115px; width: 130.637px;" rowspan="1" colspan="1">Textile</td>
                <td style="height: 115px; width: 618.363px;" rowspan="1" colspan="1">
<list list-type="bullet"><list-item><p>Tinopal CH 3566 (optical whitener in washing powder)</p></list-item><list-item><p>Naphthol AS&#x000a0;(coupling agent&#x000a0;in azo dyes)</p></list-item><list-item><p>Mercury compounds (bactericidal agent)</p></list-item><list-item><p>Formaldehyde (preservative)</p></list-item><list-item><p>Gallate (see <bold>Image.</bold> Riehl Melanosis due to Gallate)</p></list-item><list-item><p>Azo dyes</p></list-item><list-item><p>Rubber components</p></list-item><list-item><p>Chromates (as in leather)</p></list-item></list>
</td>
              </tr>
              <tr style="height: 115px;">
                <td style="height: 115px; width: 130.637px;" rowspan="1" colspan="1">Occupation</td>
                <td style="height: 115px; width: 618.363px;" rowspan="1" colspan="1">&#x000a0;
<list list-type="bullet"><list-item><p>Coal tar</p></list-item><list-item><p>Pitch</p></list-item><list-item><p>Asphalt</p></list-item><list-item><p>Mineral oil</p></list-item><list-item><p>Chromates</p></list-item><list-item><p><italic toggle="yes">Plathymenia foliosa</italic> (airborne allergen from wood dust)</p></list-item><list-item><p>Nickel sulfate (metal products)</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="article-28584.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>A typical patient with Riehl melanosis is an older woman with a darker skin type who applies cosmetic products to her face or neck. Riehl melanosis is predominantly observed in women than men and has been noted to correspond with the reproductive cycle, suggesting hormonal mediation.<xref ref-type="bibr" rid="article-28584.r25">[25]</xref>&#x000a0;The condition is particularly observed to be prevalent in individuals with darker skin tones, notably those of Asian or Hispanic origin.<xref ref-type="bibr" rid="article-28584.r26">[26]</xref>&#x000a0;Riehl melanosis is more frequently encountered in older individuals, often associated with practices such as hair coloring with henna, and is rare among younger patients.<xref ref-type="bibr" rid="article-28584.r13">[13]</xref>&#x000a0;Although precise data on the incidence and prevalence of Riehl melanosis remain unknown, evidence suggests an increasing trend.<xref ref-type="bibr" rid="article-28584.r27">[27]</xref></p>
      </sec>
      <sec id="article-28584.s5" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>A skin biopsy is considered the gold standard for diagnosing Riehl melanosis, although in some cases, a thorough clinical history may be adequate without the need for a biopsy.<xref ref-type="bibr" rid="article-28584.r1">[1]</xref>&#x000a0;When a skin biopsy is performed, histopathological features characteristic of Riehl melanosis may include the following findings:<xref ref-type="bibr" rid="article-28584.r28">[28]</xref><xref ref-type="bibr" rid="article-28584.r29">[29]</xref><xref ref-type="bibr" rid="article-28584.r3">[3]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Basal vacuolar degeneration with colloid bodies</p>
          </list-item>
          <list-item>
            <p>Pigment incontinence with pilosebaceous involvement</p>
          </list-item>
          <list-item>
            <p>Increased dermal melanophages and increased epidermal melanocytes</p>
          </list-item>
          <list-item>
            <p>Perivascular, epidermal, or dermal inflammatory infiltrates (such as mononuclear cells, eosinophils, and lymphocytes)&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Dilated blood vessels</p>
          </list-item>
          <list-item>
            <p>Interface changes</p>
          </list-item>
          <list-item>
            <p>Hypergranulosis (although more common in lichen planus pigmentosus)</p>
          </list-item>
          <list-item>
            <p>Epidermal spongiosis</p>
          </list-item>
        </list>
        <p>Perilesional skin may show similar features but to a lesser extent. Generally, the&#x000a0;histopathology of Riehl melanosis may be nonspecific. The use of melanin stains (such as Melan-A and Fontana-Masson) may reveal increased melanin deposition.<xref ref-type="bibr" rid="article-28584.r29">[29]</xref></p>
      </sec>
      <sec id="article-28584.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Patients with Riehl melanosis may present with erythema, edema, and pruritus preceding pigmentation or with pigmentation alone. This initial inflammatory phase putatively underlies the onset of allergic contact dermatitis.<xref ref-type="bibr" rid="article-28584.r20">[20]</xref><xref ref-type="bibr" rid="article-28584.r30">[30]</xref>&#x000a0;Upon physical examination, patients may exhibit patchy-to-diffuse hyperpigmentation, which may appear scaly and accompanied by nearby satellite perifollicular pigmented macules. These macules are typically a few millimeters in size, in contrast to the larger patches commonly observed in conditions such as lichen planus pigmentosus and erythema dyschromicum perstans (also known as ashy dermatosis).<xref ref-type="bibr" rid="article-28584.r1">[1]</xref> A reticulated pattern is often evident at the center of the pigmented areas.<xref ref-type="bibr" rid="article-28584.r20">[20]</xref><xref ref-type="bibr" rid="article-28584.r7">[7]</xref>&#x000a0;The shades of pigmentation, which may vary from brown to blue or gray, depend on factors such as severity, skin type, and causal agents (see <bold>Image.</bold> Riehl Melanosis on Bilateral Cheeks).<xref ref-type="bibr" rid="article-28584.r20">[20]</xref><xref ref-type="bibr" rid="article-28584.r7">[7]</xref>&#x000a0;</p>
        <p>The usual presentation of Riehl melanosis occurs on the face, with the forehead, temple, or zygomatic areas being the most frequently affected regions. In cases associated with textiles, Riehl melanosis manifests on the anterior thighs or axillae while sparing the vault.<xref ref-type="bibr" rid="article-28584.r20">[20]</xref><xref ref-type="bibr" rid="article-28584.r22">[22]</xref> When the implicated allergens are photosensitizers, pigmentation tends to be more pronounced in sun-exposed areas such as the chest, neck, scalp, or hands.<xref ref-type="bibr" rid="article-28584.r31">[31]</xref></p>
      </sec>
      <sec id="article-28584.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosing and evaluating Riehl melanosis can pose challenges. Diagnostic tools include skin biopsy, dermoscopy, reflectance confocal microscopy, and patch testing. While a skin biopsy may aid in diagnosing Riehl melanosis, patients may decline due to concerns about scarring or undesirable cosmetic outcomes, especially in cosmetically sensitive areas affected by the condition. Skin biopsies are often unnecessary or inappropriate if a contact allergen can be identified.<xref ref-type="bibr" rid="article-28584.r1">[1]</xref>&#x000a0;Ongoing research explores newer diagnostic tools, including serum biomarkers, such as guanine deaminase, and optical coherence tomography. Cellular resolution optical coherence tomography imaging can reveal melanocyte capping, basement membrane degeneration, telangiectasias, and dermal melanophages.<xref ref-type="bibr" rid="article-28584.r32">[32]</xref>&#x000a0;</p>
        <p><bold>Dermoscopy</bold>Dermoscopy reveals pseudo networks characterized by brown or gray dots and globules arranged in an arcuate, semiarcuate, or hexagonal pattern.<xref ref-type="bibr" rid="article-28584.r33">[33]</xref> Additionally, telangiectasias, scale, perifollicular hypopigmented halos, and follicular keratotic plugs have been observed.<xref ref-type="bibr" rid="article-28584.r3">[3]</xref>&#x000a0;A grading scale based on dermoscopy categorizes the dermoscopic features of Riehl melanosis into 4 grades, which include:<xref ref-type="bibr" rid="article-28584.r5">[5]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Grade 1: Randomly distributed sparse dots with light brown macules and patches.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Grade 2: Dots with occasional globules, appearing as broken or semiarcuate formations.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Grade 3: Reticulate dots and globules with occasional blotches.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Grade 4: Thick spots, globules, and blotches with pigment network destruction, clinically presenting as widespread brown-black discoloration</p>
          </list-item>
        </list>
        <p><bold>Reflectance Confocal Microscopy</bold>Upon correlation with conventional histopathologic examination, findings consistent with disorders of increased pigmentation are observed.<xref ref-type="bibr" rid="article-28584.r28">[28]</xref>&#x000a0;These findings include multiple bright, refractile oval-to-stellate melanophages and basal layer liquefactive changes, which are characteristic of acquired dermal macular hyperpigmentation.<xref ref-type="bibr" rid="article-28584.r1">[1]</xref><xref ref-type="bibr" rid="article-28584.r34">[34]</xref>&#x000a0;Reflectance confocal microscopy mirrors the following features seen in histopathology:<xref ref-type="bibr" rid="article-28584.r28">[28]</xref><xref ref-type="bibr" rid="article-28584.r15">[15]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Epidermal or superficial dermal inflammatory cell infiltrates, such as monocytes.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Basal layer vacuolar degeneration with obscured papillary rims and obliteration of the ring-like dermal papillae.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Pigment incontinence.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Dilated vessels with prominent surrounding&#x000a0;linear or round&#x000a0;canalicular structures.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Dilated, hyperkeratotic infundibula with highly refractive material</p>
          </list-item>
        </list>
        <p><bold>Patch Testing</bold>Patch testing is recommended to identify a potential causative agent that patients may continue to use, promoting low-level chronic inflammation consistent with the condition.<xref ref-type="bibr" rid="article-28584.r3">[3]</xref> Closed patch testing should be performed with standard series, cosmetic series, fragrance series, and other patient-provided products.<xref ref-type="bibr" rid="article-28584.r1">[1]</xref>&#x000a0;For patients with suspected photoallergy, photopatch testing should be pursued. Patch testing has been shown to identify the cause of Riehl melanosis in approximately 80% of cases.<xref ref-type="bibr" rid="article-28584.r3">[3]</xref>&#x000a0;Standard closed-patch testing may prove inadequate for diagnosis due to the low allergen concentration. In cases where patients exhibit a negative test result but maintain a high clinical suspicion for Riehl melanosis or when the result is equivocal, a repeated open application test (ROAT) is recommended.<xref ref-type="bibr" rid="article-28584.r1">[1]</xref> If the ROAT yields equivocal results on the forearm, further evaluation on the face or other affected areas should be conducted.<xref ref-type="bibr" rid="article-28584.r22">[22]</xref></p>
        <p><bold>Monitoring</bold>Clinical improvement can be measured with the DPASI, an objective scoring system of 6 facial segments: forehead, left cheek, right cheek, central face (from the glabella to the chin extending laterally from the medial canthus of the eye to the lateral edges of the oral commissure).<xref ref-type="bibr" rid="article-28584.r35">[35]</xref>&#x000a0;In each segment, dermoscopy grading (which is&#x000a0;correlated with histopathologic findings) on a 1&#x000a0;to 4 grading scale is multiplied by a factor based on the surface area of the segment.&#x000a0;The DPASI was validated in a&#x000a0;study of 55 patients&#x000a0;as a reliable indicator of acquired dermal macular hyperpigmentation severity.<xref ref-type="bibr" rid="article-28584.r9">[9]</xref></p>
        <p>The following calculation results in a score ranging from 0 to 40:</p>
        <p>DPASI = Forehead + Left cheek + Right cheek + Central face + Left neck + Right neck, where</p>
        <list list-type="bullet">
          <list-item>
            <p>Forehead = % forehead involvement &#x000d7; dermoscopy grade &#x000d7; 2</p>
          </list-item>
          <list-item>
            <p>Left&#x000a0;cheek =&#x000a0;%&#x000a0;left cheek involvement &#x000d7; dermoscopy grade &#x000d7; 2</p>
          </list-item>
          <list-item>
            <p>Right&#x000a0;cheek =&#x000a0;%&#x000a0;right cheek involvement &#x000d7; dermoscopy grade &#x000d7; 2</p>
          </list-item>
          <list-item>
            <p>Central face =&#x000a0;%&#x000a0;central face involvement &#x000d7; dermoscopy grade &#x000d7; 1</p>
          </list-item>
          <list-item>
            <p>Left neck =&#x000a0;%&#x000a0;left neck&#x000a0;involvement &#x000d7; dermoscopy grade &#x000d7; 1.5</p>
          </list-item>
          <list-item>
            <p>Right neck =&#x000a0;%&#x000a0;right neck involvement &#x000d7; dermoscopy grade &#x000d7; 1.5&#x000a0;<xref ref-type="bibr" rid="article-28584.r36">[36]</xref><xref ref-type="bibr" rid="article-28584.r35">[35]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28584.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>All individuals with Riehl melanosis should avoid using products containing identified allergens and adhere to regular sun protection measures.<xref ref-type="bibr" rid="article-28584.r13">[13]</xref>&#x000a0;Although several therapeutic approaches have been proposed with variable results, a definitive treatment or cure for Riehl melanosis is yet to be established, and treatment outcomes may vary depending on the chosen modality.<xref ref-type="bibr" rid="article-28584.r20">[20]</xref><xref ref-type="bibr" rid="article-28584.r23">[23]</xref>&#x000a0;Studied treatment modalities include both medical and procedural treatments.</p>
        <p>
<bold>Medical Therapies</bold>
</p>
        <p>Topical therapies encompass&#x000a0;a range of options, including hydroquinone (2% or 4% cream), retinoids, topical corticosteroids, kojic acid, glycolic acid, azelaic acid, and lignin peroxidase.<xref ref-type="bibr" rid="article-28584.r4">[4]</xref><xref ref-type="bibr" rid="article-28584.r1">[1]</xref><xref ref-type="bibr" rid="article-28584.r23">[23]</xref><xref ref-type="bibr" rid="article-28584.r1">[1]</xref>&#x000a0;Lignin peroxidase is an&#x000a0;enzyme derived from <italic toggle="yes">Phanerochaete chrysosporium</italic>, a fungus in woody plants, which exhibits melanin decolorization properties.<xref ref-type="bibr" rid="article-28584.r37">[37]</xref>&#x000a0;In a split-face study involving 60 women with facial dyspigmentation, lignin peroxidase demonstrated notable improvements in skin texture, roughness, and overall appearance by week 2, with a reduction in spot size observed by week 12 compared to untreated areas. Compared to hydroquinone, lignin peroxidase exhibited similar efficacy but showed superior outcomes in skin texture and roughness.<xref ref-type="bibr" rid="article-28584.r38">[38]</xref>&#x000a0;Lignin peroxidase lotion has demonstrated efficacy in treating melasma, with reported improvements in luminance.<xref ref-type="bibr" rid="article-28584.r39">[39]</xref>&#x000a0;In a randomized, double-blind, placebo-controlled, split-face single-center study involving 51 patients, the use of lignin peroxidase cream twice daily significantly reduced the melanin index compared to both placebo and 2% hydroquinone cream.<xref ref-type="bibr" rid="article-28584.r40">[40]</xref></p>
        <p>A&#x000a0;few oral therapies used to treat Riehl melanosis are listed below.</p>
        <p><bold>Tranexamic acid:</bold> Tranexamic acid is a lysine derivative utilized in the treatment of Riehl melanosis functions by obstructing melanocyte-keratinocyte interactions through the plasmin-plasminogen system. This acid putatively inhibits melanin synthesis in melanocytes and inhibits neovascularization.<xref ref-type="bibr" rid="article-28584.r4">[4]</xref> A regimen of oral tranexamic acid (500 mg) combined with glycyrrhizin compound (150 mg) daily over a period of 3 weeks has shown efficacy in treating Riehl melanosis. In a study involving 10 patients, 7 exhibited marked improvement in both the Melanin Index and the Erythema Index.<xref ref-type="bibr" rid="article-28584.r41">[41]</xref>&#x000a0;</p>
        <p><bold>Glycyrrhizin:</bold> Glycyrrhizic acid (glycyrrhizin), the active component of licorice root, exhibits steroid-like properties. In oral form, it demonstrates anti-inflammatory and immunomodulatory effects, making it useful in various pigmentation disorders, including vitiligo.<xref ref-type="bibr" rid="article-28584.r42">[42]</xref><xref ref-type="bibr" rid="article-28584.r43">[43]</xref>&#x000a0;In patients with Riehl melanosis, glycyrrhizin decreases&#x000a0;inflammation, pruritus, erythema, and edema.<xref ref-type="bibr" rid="article-28584.r4">[4]</xref>&#x000a0;However, caution is warranted due to potential adverse effects stemming from its impact on the renin-angiotensin-aldosterone system.<xref ref-type="bibr" rid="article-28584.r44">[44]</xref></p>
        <p><bold>Mycophenolate mofetil:</bold> Mycophenolate mofetil, an immunomodulator and immunosuppressive agent, acts by targeting purine production to decrease melanin content in affected areas.<xref ref-type="bibr" rid="article-28584.r4">[4]</xref> In an open-label pilot study involving 43 patients with acquired dermal macular hyperpigmentation, the use of mycophenolate mofetil resulted in significant improvement in DPASI scores.<xref ref-type="bibr" rid="article-28584.r45">[45]</xref><xref ref-type="bibr" rid="article-28584.r19">[19]</xref></p>
        <p><bold>Procedural Therapies</bold>Procedural treatments for Riehl melanosis include chemical peels and laser or light therapy. Chemical peels induce controlled epidermal and dermal destruction, promoting skin remodeling and rejuvenation, thus improving Riehl melanosis.<xref ref-type="bibr" rid="article-28584.r46">[46]</xref>&#x000a0;Salicylic acid, azelaic acid, and glycolic acid peels have demonstrated efficacy in Riehl melanosis treatment.<xref ref-type="bibr" rid="article-28584.r47">[47]</xref><xref ref-type="bibr" rid="article-28584.r23">[23]</xref><xref ref-type="bibr" rid="article-28584.r20">[20]</xref>&#x000a0;Additionally, pulsed-type microneedling radiofrequency has shown promise in 44 patients with melasma or Riehl melanosis. Patients received 5 treatments at 2-week intervals, resulting in clinical improvement evidenced by decreases in the Erythema Index, Melanin Index, transepidermal water loss, and histopathologic findings indicating reduced melanin, melanophages, and dermal vascular proliferation, along with decreased CD44 and basic-fibroblast growth factor expression.<xref ref-type="bibr" rid="article-28584.r48">[48]</xref></p>
        <p>Various laser modalities have shown promise in treating&#x000a0;Riehl melanosis. The 1064-nm quality-switched (Q-switched) neodymium-doped yttrium aluminum garnet (Nd:YAG) laser used at lower fluence (to reduce adverse effects like postinflammatory hyperpigmentation) is&#x000a0;the most studied laser for&#x000a0;Riehl melanosis, and it has even been used for cases refractory to other laser treatments like intense pulsed light therapy.<xref ref-type="bibr" rid="article-28584.r49">[49]</xref><xref ref-type="bibr" rid="article-28584.r50">[50]</xref><xref ref-type="bibr" rid="article-28584.r51">[51]</xref><xref ref-type="bibr" rid="article-28584.r52">[52]</xref>&#x000a0;Other&#x000a0;laser and light treatments for Riehl melanosis include the 755-nm ps alexandrite laser, nonablative 1927-nm fractional thulium fiber laser, and intense pulsed light therapy.<xref ref-type="bibr" rid="article-28584.r53">[53]</xref><xref ref-type="bibr" rid="article-28584.r54">[54]</xref><xref ref-type="bibr" rid="article-28584.r55">[55]</xref> Combining fractional picosecond laser with pulsed dye laser to target dermal melanin and vessels has shown greater efficacy than using a single laser to target pigmentation alone, as measured by DPASI.<xref ref-type="bibr" rid="article-28584.r56">[56]</xref>&#x000a0;However, adverse effects such as postinflammatory hyperpigmentation, hypopigmentation, rebound aggravation, and guttate hypopigmentation may occur with laser treatments.<xref ref-type="bibr" rid="article-28584.r1">[1]</xref>&#x000a0;</p>
        <p><bold>Combination Therapies</bold>Combining multiple therapies may be necessary for&#x000a0;recalcitrant forms and could even be considered an initial treatment.<xref ref-type="bibr" rid="article-28584.r47">[47]</xref><xref ref-type="bibr" rid="article-28584.r41">[41]</xref><xref ref-type="bibr" rid="article-28584.r57">[57]</xref>&#x000a0;Combinations of treatment modalities&#x000a0;for Riehl melanosis&#x000a0;include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Combining low-fluence 1064-nm quality-switched (Q-switched) neodymium-doped yttrium aluminum garnet (Nd:YAG) laser, hydroquinone cream, and oral tranexamic acid was found to improve Riehl melanosis in 8 patients significantly.<xref ref-type="bibr" rid="article-28584.r57">[57]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>In a retrospective study of 10 patients in Korea, combining 1064-nm Q-switched Nd:YAG laser with hydroquinone resulted in near-total improvement for most patients, with a mean of 12.1 and 14.6 low-fluence Nd:YAG treatments for marked and near-total improvement, respectively.<xref ref-type="bibr" rid="article-28584.r58">[58]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Glycyrrhizin compound at a dosage of 150 mg/d and vitamin C at 100 mg/d, along with salicylic acid peels at a concentration of 30% once every 2 weeks, proved to be a safe and effective treatment for Riehl melanosis in 3 patients.<xref ref-type="bibr" rid="article-28584.r47">[47]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Oral tranexamic acid at a dosage of 250 mg/d combined with 4% hydroquinone application and Nd:YAG laser treatment administered every 3 weeks showed improvement in mixed melasma.<xref ref-type="bibr" rid="article-28584.r59">[59]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>In another study involving 28 patients with refractory Riehl melanosis, treatment with oral tranexamic acid at a dosage of 500 mg daily along with monthly intense pulsed light therapy resulted in better improvement in DPASI and Melanin Index compared to tranexamic acid treatment alone.<xref ref-type="bibr" rid="article-28584.r60">[60]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28584.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Riehl melanosis must be differentiated from other conditions categorized under acquired dermal macular pigmentation (previously termed macular pigmentation of uncertain etiology). This spectrum includes Riehl melanosis, erythema dyschromia perstans (also known as ashy dermatosis), lichen planus pigmentosus, melasma, exogenous ochronosis, idiopathic macular eruptive pigmentation, and pigmented contact dermatitis.<xref ref-type="bibr" rid="article-28584.r2">[2]</xref><xref ref-type="bibr" rid="article-28584.r8">[8]</xref>&#x000a0;The acquired dermal macular pigmentation disorders have similar clinical and histopathological findings.<xref ref-type="bibr" rid="article-28584.r9">[9]</xref></p>
        <p>Some&#x000a0;differential diagnoses related&#x000a0;to Riehl melanosis include the following conditions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Lichen planus pigmentosus presents as a diffuse slate-gray&#x000a0;or black pigmentation affecting overexposed areas and flexures. This condition is generally associated with classic lichen planus.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Poikiloderma of Civatte manifests clinically as dark pigmentation with a reticulate distribution, telangiectasia, and atrophy on the sides of the neck. Photodynamic substances in cosmetics may have a significant role in its development.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Erythromelanosis follicularis of the face and neck is characterized by follicular papules surrounded by red-brown pigmentation and causes hair loss. The etiology of this condition is unknown.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Erythrosis pigmentosa mediofacialis (also known as erythrose peribuccale pigmentaire or Brocq) typically appears as a brown-red pigmentation around the mouth, sparing the vermillion border. Photodynamic molecules in cosmetics are believed to contribute to its development.&#x000a0;&#x000a0;</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Linea fusca is characterized by an arciform brown-yellow pigmentation near the hair implantation, primarily affecting the forehead and temporal areas. Other dark patches may appear across the face. This condition is often associated with the use of cosmetics and hat ribbons, although it could also indicate underlying conditions such as encephalitis, central nervous tumors, or neurosyphilis.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Erythema dyschromicum perstans (also known as ashy dermatosis) manifests as multiple asymptomatic, gradually enlarging hyperpigmented macules with a raised erythematous border. These lesions may merge and cover extensive areas of the face, trunk, and limbs.<xref ref-type="bibr" rid="article-28584.r20">[20]</xref><xref ref-type="bibr" rid="article-28584.r61">[61]</xref><xref ref-type="bibr" rid="article-28584.r23">[23]</xref></p>
          </list-item>
        </list>
        <p>Histologically, these diseases exhibit a lichenoid reaction along with other characteristic findings. Other conditions to consider in the differential diagnosis include drug-induced melanoderma (causative drugs include tetracyclines, salicylamides, sulfonamides, chlorpromazine, chlorothiazides, some oral antidiabetics, phenothiazines, minocycline, antimalarials, psychotropic drugs, chemotherapeutic agents, and psoralens), melasma, Nevus of Ota, Hori nevus, Addison disease, exogenous ochronosis, postinflammatory hyperpigmentation, idiopathic eruptive macular pigmentation, allergic contact dermatitis, and irritant dermatitis.</p>
      </sec>
      <sec id="article-28584.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Riehl melanosis is not considered life-threatening; however, it poses an increased risk of psychosocial effects as the pigmentation may cause distress to patients.<xref ref-type="bibr" rid="article-28584.r33">[33]</xref> Although the pigmentation tends to lighten over time, it may persist for months or even years. Resistant cases or relapses of Riehl melanosis are not uncommon, particularly if a causative allergen is identified but not avoided.</p>
      </sec>
      <sec id="article-28584.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of Riehl melanosis may include poor cosmesis, anxiety, depression, or poor quality of life, usually related to the physical appearance associated with the condition.</p>
      </sec>
      <sec id="article-28584.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should diligently adhere to instructions aimed at minimizing the appearance of Riehl melanosis, which may include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Avoiding exposure to the causative allergen.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Using skincare products free of allergens when applicable.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Implementing sun protection measures such as applying broad-spectrum sunscreen (with protection against visible light)&#x000a0;and wearing appropriate clothing.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Steering clear of peak sunlight exposure in affected and other susceptible areas.</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Maintaining continued treatment, as noticeable improvement may take several weeks or months to manifest.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-28584.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with&#x000a0;Riehl melanosis&#x000a0;may require prolonged treatment courses along with regular education to improve this condition. Early identification and intervention for individuals with Riehl melanosis are crucial in mitigating morbidity. The care for&#x000a0;patients with Riehl melanosis requires a collaborative approach among healthcare professionals to ensure patient-centered care and enhance overall outcomes. Dermatologists, primary care physicians, cosmetic surgeons, plastic surgeons, allergists, advanced practitioners, nurses, pharmacists, and other healthcare providers involved&#x000a0;in the treatment process should possess the requisite clinical skills and knowledge to accurately diagnose and manage Riehl melanosis. This includes proficiency in recognizing diverse clinical presentations and comprehending the intricacies of diagnostic techniques such as dermoscopy and reflectance confocal microscopy. By working together, these teams can enhance the detection and treatment of Riehl melanosis. Educating patients and caregivers about triggering factors, medication adherence, and optimal practices is crucial for preventing morbidity associated with Riehl melanosis.</p>
        <p>A strategic approach is equally crucial, entailing evidence-based strategies to optimize treatment plans while mitigating adverse effects. Ethical considerations must guide decision-making, ensuring informed consent and respecting patient autonomy in treatment decisions. Each healthcare professional must understand their responsibilities and contribute their unique expertise to the patient's care plan, fostering a multidisciplinary approach. Effective interprofessional communication is paramount, enabling seamless information exchange and collaborative decision-making among team members. Care coordination plays a pivotal role in ensuring that the patient's journey from diagnosis to treatment and follow-up is well-managed, minimizing errors and enhancing patient safety. By prioritizing skill, strategy, ethics, responsibilities, interprofessional communication, and care coordination, healthcare professionals can deliver patient-centered care, ultimately improving patient outcomes and enhancing team performance in the management of Riehl melanosis.</p>
      </sec>
      <sec id="article-28584.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=28584&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=28584">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/riehl-melanosis/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=28584">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/28584/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=28584">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-28584.s15">
        <fig id="article-28584.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Clinical Photographs of Riehl Melanosis. The images show brown mottled patches on the face and neck (A), slate-gray patches on the lateral face and neck (B), and gray patches on the face and neck (C) of patients with Riehl melanosis. Lee YJ, Park JH, Lee DY, Lee JH. Acquired bilateral dyspigmentation on face and neck: clinically appropriate approaches. <italic toggle="yes">J Korean Med Sci.</italic> 2016;31(12):2042-2050. doi:&#x000a0;10.3346/ jkms.2016.31.12.2042.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28584.s16">
        <fig id="article-28584.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Riehl Melanosis on the Left Cheek. The left image shows a brown-gray patch on the left cheek, while the right image depicts positive patch testing for Fair &#x00026; Handsome cream in a patient with Riehl melanosis. Prabha N, Mahajan VK, Mehta KS, Chauhan PS, Gupta M. Cosmetic contact sensitivity in patients with melasma: results of a pilot study. <italic toggle="yes">Dermatol Res Pract.</italic> 2014;2014:316219. doi: 10.1155/2014/316219.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28584.s17">
        <fig id="article-28584.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Riehl Melanosis on Bilateral Cheeks. The left image displays brown-gray reticulated, mottled patches on the bilateral cheeks, while the right image shows a positive patch test for cetrimide in a patient with Riehl melanosis. Prabha N, Mahajan VK, Mehta KS, Chauhan PS, Gupta M. Cosmetic contact sensitivity in patients with melasma: results of a pilot study. <italic toggle="yes">Dermatol Res Pract.</italic> 2014;2014:316219. doi: 10.1155/2014/316219.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image3" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28584.s18">
        <fig id="article-28584.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Riehl Melanosis due to Gallate. The left image shows mottled brown-gray face discoloration, while the right image displays a positive patch test result for gallate mix in a patient with Riehl melanosis. Prabha N, Mahajan VK, Mehta KS, Chauhan PS, Gupta M. Cosmetic contact sensitivity in patients with melasma: results of a pilot study. <italic toggle="yes">Dermatol Res Pract.</italic> 2014;2014:316219. doi: 10.1155/2014/316219.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image4" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-28584.s19">
        <fig id="article-28584.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Kumkum-Induced Pigmented Contact Dermatitis. The image depicts a brown-gray hyperpigmented plaque on the glabella resulting from kumkum-induced pigmented contact dermatitis. Gupta D, Thappa DM. Dermatoses due to Indian cultural practices. <italic toggle="yes">Indian J Dermatol.</italic> 2015;60(1):3-12. doi:10.4103/0019-5154.147778.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Image5" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-28584.s20">
        <title>References</title>
        <ref id="article-28584.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ding</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>LF</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment.</article-title>
            <source>Pigment Cell Melanoma Res</source>
            <year>2023</year>
            <month>Nov</month>
            <volume>36</volume>
            <issue>6</issue>
            <fpage>455</fpage>
            <page-range>455-467</page-range>
            <pub-id pub-id-type="pmid">37401632</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shah</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Baskaran</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Vinay</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bishnoi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parsad</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kumaran</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Acquired dermal macular hyperpigmentation: an overview of the recent updates.</article-title>
            <source>Int J Dermatol</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>62</volume>
            <issue>12</issue>
            <fpage>1447</fpage>
            <page-range>1447-1457</page-range>
            <pub-id pub-id-type="pmid">37767951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sitohang</surname>
                <given-names>IBS</given-names>
              </name>
              <name>
                <surname>Prayogo</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Rihatmadja</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sirait</surname>
                <given-names>SP</given-names>
              </name>
            </person-group>
            <article-title>The diagnostic conundrum of Riehl melanosis and other facial pigmentary disorders: a case report with overlapping clinical, dermoscopic, and histopathological features.</article-title>
            <source>Acta Dermatovenerol Alp Pannonica Adriat</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>29</volume>
            <issue>2</issue>
            <fpage>81</fpage>
            <page-range>81-83</page-range>
            <pub-id pub-id-type="pmid">32566956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mu</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Research Advances in the Treatment of Riehl's Melanosis.</article-title>
            <source>Clin Cosmet Investig Dermatol</source>
            <year>2023</year>
            <volume>16</volume>
            <fpage>1181</fpage>
            <page-range>1181-1189</page-range>
            <pub-id pub-id-type="pmid">37168093</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vinay</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bishnoi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Parsad</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Saikia</surname>
                <given-names>UN</given-names>
              </name>
              <name>
                <surname>Sendhil Kumaran</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Dermatoscopic evaluation and histopathological correlation of acquired dermal macular hyperpigmentation.</article-title>
            <source>Int J Dermatol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>56</volume>
            <issue>12</issue>
            <fpage>1395</fpage>
            <page-range>1395-1399</page-range>
            <pub-id pub-id-type="pmid">28971471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>rorsman</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Riehl's melanosis.</article-title>
            <source>Int J Dermatol</source>
            <year>1982</year>
            <month>Mar</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>75</fpage>
            <page-range>75-8</page-range>
            <pub-id pub-id-type="pmid">7068304</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nakayama</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Matsuo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hayakawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takhashi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Shigematsu</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ota</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Pigmented cosmetic dermatitis.</article-title>
            <source>Int J Dermatol</source>
            <year>1984</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>299</fpage>
            <page-range>299-305</page-range>
            <pub-id pub-id-type="pmid">6746179</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Friedman</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Mohammad</surname>
                <given-names>TF</given-names>
              </name>
            </person-group>
            <article-title>Disorders of hyperpigmentation. Part I. Pathogenesis and clinical features of common pigmentary disorders.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>88</volume>
            <issue>2</issue>
            <fpage>271</fpage>
            <page-range>271-288</page-range>
            <pub-id pub-id-type="pmid">35151757</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sarkar</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vinay</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bishnoi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Poojary</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kumaran</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gurumurthy</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arora</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kandhari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Rathi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zawar</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ravivarma</surname>
                <given-names>VN</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Parsad</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>A Delphi consensus on the nomenclature and diagnosis of lichen planus pigmentosus and related entities.</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2023</year>
            <season>Jan-Frebuary</season>
            <volume>89</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-46</page-range>
            <pub-id pub-id-type="pmid">35593293</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lai</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zheng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Zhou</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Coexistence of Riehl's Melanosis, Lupus Erythematosus and Thyroiditis in a Patient.</article-title>
            <source>Clin Cosmet Investig Dermatol</source>
            <year>2022</year>
            <volume>15</volume>
            <fpage>1809</fpage>
            <page-range>1809-1813</page-range>
            <pub-id pub-id-type="pmid">36105748</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jung</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Noh</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Jo</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SY</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Guanine Deaminase in Human Epidermal Keratinocytes Contributes to Skin Pigmentation.</article-title>
            <source>Molecules</source>
            <year>2020</year>
            <month>Jun</month>
            <day>05</day>
            <volume>25</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">32517074</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>CCN1/Cyr61 Stimulates Melanogenesis through Integrin &#x003b1;6&#x003b2;1, p38 MAPK, and ERK1/2 Signaling Pathways in Human Epidermal Melanocytes.</article-title>
            <source>J Invest Dermatol</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>138</volume>
            <issue>8</issue>
            <fpage>1825</fpage>
            <page-range>1825-1833</page-range>
            <pub-id pub-id-type="pmid">29510193</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woo</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Lim</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Yu</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Acquired diffuse slate-grey facial dyspigmentation due to henna: an unrecognized cause of pigment contact dermatitis in Korean patients.</article-title>
            <source>Eur J Dermatol</source>
            <year>2018</year>
            <month>Oct</month>
            <day>01</day>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>644</fpage>
            <page-range>644-648</page-range>
            <pub-id pub-id-type="pmid">30530434</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sugai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takagi</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Pigmented cosmetic dermatitis and coal tar dyes.</article-title>
            <source>Contact Dermatitis</source>
            <year>1977</year>
            <month>Oct</month>
            <volume>3</volume>
            <issue>5</issue>
            <fpage>249</fpage>
            <page-range>249-56</page-range>
            <pub-id pub-id-type="pmid">589997</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lu</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Progress in the application of reflectance confocal microscopy in dermatology.</article-title>
            <source>Postepy Dermatol Alergol</source>
            <year>2021</year>
            <month>Oct</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>709</fpage>
            <page-range>709-715</page-range>
            <pub-id pub-id-type="pmid">34849113</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>AY</given-names>
              </name>
            </person-group>
            <article-title>Growth Factors Upregulated by Uric Acid Affect Guanine Deaminase-Induced Melanogenesis.</article-title>
            <source>Biomol Ther (Seoul)</source>
            <year>2023</year>
            <month>Jan</month>
            <day>01</day>
            <volume>31</volume>
            <issue>1</issue>
            <fpage>89</fpage>
            <page-range>89-96</page-range>
            <pub-id pub-id-type="pmid">36549672</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miyoshi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kodama</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Riehl's melanosis-like eruption associated with Sj&#x000f6;gren's syndrome.</article-title>
            <source>J Dermatol</source>
            <year>1997</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>12</issue>
            <fpage>784</fpage>
            <page-range>784-6</page-range>
            <pub-id pub-id-type="pmid">9492444</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Takeo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sakai</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Saito-Shono</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ishikawa</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hatano</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Katagiri</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Takahashi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kawano</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kimoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kubota</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eshima</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kojima</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Fujiwara</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Three cases of pigmented cosmetic dermatitis-like eruptions associated with primary Sj&#x000f6;gren's syndrome or anti-SSA antibody.</article-title>
            <source>J Dermatol</source>
            <year>2016</year>
            <month>Aug</month>
            <volume>43</volume>
            <issue>8</issue>
            <fpage>947</fpage>
            <page-range>947-50</page-range>
            <pub-id pub-id-type="pmid">26892480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vinay</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bishnoi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kamat</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Chatterjee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kumaran</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Parsad</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Acquired Dermal Macular Hyperpigmentation: An Update.</article-title>
            <source>Indian Dermatol Online J</source>
            <year>2021</year>
            <season>Sep-Oct</season>
            <volume>12</volume>
            <issue>5</issue>
            <fpage>663</fpage>
            <page-range>663-673</page-range>
            <pub-id pub-id-type="pmid">34667751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khanna</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Rasool</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Facial melanoses: Indian perspective.</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2011</year>
            <season>Sep-Oct</season>
            <volume>77</volume>
            <issue>5</issue>
            <fpage>552</fpage>
            <page-range>552-63; quiz 564</page-range>
            <pub-id pub-id-type="pmid">21860153</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Serrano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pujol</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cuadra</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gallo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aliaga</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Riehl's melanosis: pigmented contact dermatitis caused by fragrances.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1989</year>
            <month>Nov</month>
            <volume>21</volume>
            <issue>5 Pt 2</issue>
            <fpage>1057</fpage>
            <page-range>1057-60</page-range>
            <pub-id pub-id-type="pmid">2808836</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shenoi</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Pigmented contact dermatitis.</article-title>
            <source>Indian J Dermatol Venereol Leprol</source>
            <year>2007</year>
            <season>Sep-Oct</season>
            <volume>73</volume>
            <issue>5</issue>
            <fpage>285</fpage>
            <page-range>285-7</page-range>
            <pub-id pub-id-type="pmid">17921604</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>P&#x000e9;rez-Bernal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz-P&#x000e9;rez</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Camacho</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Management of facial hyperpigmentation.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2000</year>
            <season>Sep-Oct</season>
            <volume>1</volume>
            <issue>5</issue>
            <fpage>261</fpage>
            <page-range>261-8</page-range>
            <pub-id pub-id-type="pmid">11702317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kozuka</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Tashiro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Sano</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fujimoto</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nakamura</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Nakaminami</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Brilliant Lake Red R as a cause of pigmented contact dermatitis.</article-title>
            <source>Contact Dermatitis</source>
            <year>1979</year>
            <month>Sep</month>
            <volume>5</volume>
            <issue>5</issue>
            <fpage>297</fpage>
            <page-range>297-304</page-range>
            <pub-id pub-id-type="pmid">509931</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woo</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Jeong</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Paracrine roles of hormone receptors in Riehl's melanosis: A quantitative analysis of oestrogen and progesterone receptor expression patterns.</article-title>
            <source>Exp Dermatol</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>396</fpage>
            <page-range>396-401</page-range>
            <pub-id pub-id-type="pmid">33141431</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>HY</given-names>
              </name>
            </person-group>
            <article-title>Melasma and aspects of pigmentary disorders in Asians.</article-title>
            <source>Ann Dermatol Venereol</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>139 Suppl 4</volume>
            <fpage>S144</fpage>
            <page-range>S144-7</page-range>
            <pub-id pub-id-type="pmid">23522629</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woo</surname>
                <given-names>YR</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HJ</given-names>
              </name>
            </person-group>
            <article-title>Impact of Riehl's melanosis on quality of life in Korean patients: A cross-sectional comparative study.</article-title>
            <source>J Dermatol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>47</volume>
            <issue>8</issue>
            <fpage>893</fpage>
            <page-range>893-897</page-range>
            <pub-id pub-id-type="pmid">32592174</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Farabi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Khan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jamgochian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Atak</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Jain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rao</surname>
                <given-names>BK</given-names>
              </name>
            </person-group>
            <article-title>The role of reflectance confocal microscopy in the diagnosis and management of pigmentary disorders: A review.</article-title>
            <source>J Cosmet Dermatol</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>22</volume>
            <issue>12</issue>
            <fpage>3213</fpage>
            <page-range>3213-3222</page-range>
            <pub-id pub-id-type="pmid">37759421</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Sohn</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YC</given-names>
              </name>
            </person-group>
            <article-title>Histopathological Features of Riehl Melanosis.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>42</volume>
            <issue>2</issue>
            <fpage>117</fpage>
            <page-range>117-121</page-range>
            <pub-id pub-id-type="pmid">31990700</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ebihara</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nakayama</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Pigmented contact dermatitis.</article-title>
            <source>Clin Dermatol</source>
            <year>1997</year>
            <season>Jul-Aug</season>
            <volume>15</volume>
            <issue>4</issue>
            <fpage>593</fpage>
            <page-range>593-9</page-range>
            <pub-id pub-id-type="pmid">9255469</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lautenschlager</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Itin</surname>
                <given-names>PH</given-names>
              </name>
            </person-group>
            <article-title>Reticulate, patchy and mottled pigmentation of the neck. Acquired forms.</article-title>
            <source>Dermatology</source>
            <year>1998</year>
            <volume>197</volume>
            <issue>3</issue>
            <fpage>291</fpage>
            <page-range>291-6</page-range>
            <pub-id pub-id-type="pmid">9812039</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shen</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>YP</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Ng</surname>
                <given-names>CY</given-names>
              </name>
            </person-group>
            <article-title>Riehl's Melanosis: A Multimodality, In Vivo, Real-Time Skin Imaging Study with Cellular Resolution Optical Coherence Tomography and Advanced Skin Diagnosis System in a Tertiary Medical Center.</article-title>
            <source>Bioengineering (Basel)</source>
            <year>2022</year>
            <month>Aug</month>
            <day>26</day>
            <volume>9</volume>
            <issue>9</issue>
            <pub-id pub-id-type="pmid">36134965</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Krueger</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Saizan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Stein</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Elbuluk</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Dermoscopy of acquired pigmentary disorders: a comprehensive review.</article-title>
            <source>Int J Dermatol</source>
            <year>2022</year>
            <month>Jan</month>
            <volume>61</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-19</page-range>
            <pub-id pub-id-type="pmid">34235719</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>AE</given-names>
              </name>
            </person-group>
            <article-title>Four views of Riehl's melanosis: clinical appearance, dermoscopy, confocal microscopy and histopathology.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>28</volume>
            <issue>9</issue>
            <fpage>1199</fpage>
            <page-range>1199-206</page-range>
            <pub-id pub-id-type="pmid">24010902</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumaran</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Dabas</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vinay</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Parsad</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Reliability assessment and validation of the dermal pigmentation area and severity index: a new scoring method for acquired dermal macular hyperpigmentation.</article-title>
            <source>J Eur Acad Dermatol Venereol</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>33</volume>
            <issue>7</issue>
            <fpage>1386</fpage>
            <page-range>1386-1392</page-range>
            <pub-id pub-id-type="pmid">30801771</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Akulinina</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Dodina</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Osadchuk</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Degtyarevskaya</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Optimizing diagnostic and therapeutic measures for different types of melasma based on the biophysical characteristics of facial skin.</article-title>
            <source>J Cosmet Laser Ther</source>
            <year>2023</year>
            <month>May</month>
            <day>19</day>
            <volume>25</volume>
            <issue>1-4</issue>
            <fpage>25</fpage>
            <page-range>25-32</page-range>
            <pub-id pub-id-type="pmid">37394829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sadaqat</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Khatoon</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Malik</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Jamal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Farooq</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ali</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Urynowicz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Enzymatic decolorization of melanin by lignin peroxidase from Phanerochaete chrysosporium.</article-title>
            <source>Sci Rep</source>
            <year>2020</year>
            <month>Nov</month>
            <day>19</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>20240</fpage>
            <pub-id pub-id-type="pmid">33214596</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Draelos</surname>
                <given-names>ZD</given-names>
              </name>
            </person-group>
            <article-title>A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>72</volume>
            <issue>1</issue>
            <fpage>105</fpage>
            <page-range>105-7</page-range>
            <pub-id pub-id-type="pmid">25440437</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhong</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>HX</given-names>
              </name>
              <name>
                <surname>Niu</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Reduction of facial pigmentation of melasma by topical lignin peroxidase: A novel fast-acting skin-lightening agent.</article-title>
            <source>Exp Ther Med</source>
            <year>2015</year>
            <month>Feb</month>
            <volume>9</volume>
            <issue>2</issue>
            <fpage>341</fpage>
            <page-range>341-344</page-range>
            <pub-id pub-id-type="pmid">25574195</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mauricio</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Karmon</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Khaiat</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>A randomized and placebo-controlled study to compare the skin-lightening efficacy and safety of lignin peroxidase cream vs. 2% hydroquinone cream.</article-title>
            <source>J Cosmet Dermatol</source>
            <year>2011</year>
            <month>Dec</month>
            <volume>10</volume>
            <issue>4</issue>
            <fpage>253</fpage>
            <page-range>253-9</page-range>
            <pub-id pub-id-type="pmid">22151932</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Xing</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Flora Xiang</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>A pilot study of oral tranexamic acid and Glycyrrhizin compound in the treatment of recalcitrant Riehl's melanosis.</article-title>
            <source>J Cosmet Dermatol</source>
            <year>2019</year>
            <month>Feb</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>286</fpage>
            <page-range>286-292</page-range>
            <pub-id pub-id-type="pmid">30341831</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Li</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ma</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Effect of vitiligo treatment using compound glycyrrhizin combined with fractional carbon dioxide laser and topical triamcinolone acetonide on serum interleukin-17 and tissue growth factor-<bold><italic>&#x003b2;</italic></bold> levels.</article-title>
            <source>J Int Med Res</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>47</volume>
            <issue>11</issue>
            <fpage>5623</fpage>
            <page-range>5623-5631</page-range>
            <pub-id pub-id-type="pmid">31550958</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mou</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Han</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>WL</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Combination therapy of orally administered glycyrrhizin and UVB improved active-stage generalized vitiligo.</article-title>
            <source>Braz J Med Biol Res</source>
            <year>2016</year>
            <month>Jul</month>
            <day>25</day>
            <volume>49</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">27464024</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>St&#x000f8;rmer</surname>
                <given-names>FC</given-names>
              </name>
              <name>
                <surname>Reistad</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Glycyrrhizic acid in liquorice--evaluation of health hazard.</article-title>
            <source>Food Chem Toxicol</source>
            <year>1993</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>303</fpage>
            <page-range>303-12</page-range>
            <pub-id pub-id-type="pmid">8386690</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bishnoi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vinay</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Parsad</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kumar</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chatterjee</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Nahar Saikia</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Sendhil Kumaran</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Oral mycophenolate mofetil in the treatment of acquired dermal macular hyperpigmentation: An open-label pilot study.</article-title>
            <source>Australas J Dermatol</source>
            <year>2021</year>
            <month>Aug</month>
            <volume>62</volume>
            <issue>3</issue>
            <fpage>278</fpage>
            <page-range>278-285</page-range>
            <pub-id pub-id-type="pmid">33660856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Ahuja</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Chemical peel as an adjuvant treatment in pigmented contact dermatitis: a case series.</article-title>
            <source>J Cosmet Laser Ther</source>
            <year>2022</year>
            <month>Nov</month>
            <day>17</day>
            <volume>24</volume>
            <issue>6-8</issue>
            <fpage>112</fpage>
            <page-range>112-117</page-range>
            <pub-id pub-id-type="pmid">36384385</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wen</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Hao</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Du</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Combination therapy with salicylic acid chemical peels, glycyrrhizin compound, and vitamin C for Riehl's melanosis.</article-title>
            <source>J Cosmet Dermatol</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>19</volume>
            <issue>6</issue>
            <fpage>1377</fpage>
            <page-range>1377-1380</page-range>
            <pub-id pub-id-type="pmid">31524950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Park</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Ro</surname>
                <given-names>YS</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Therapeutic Effects of New Pulsed-Type Microneedling Radiofrequency for Refractory Facial Pigmentary Disorders.</article-title>
            <source>Dermatol Surg</source>
            <year>2022</year>
            <month>Mar</month>
            <day>01</day>
            <volume>48</volume>
            <issue>3</issue>
            <fpage>327</fpage>
            <page-range>327-333</page-range>
            <pub-id pub-id-type="pmid">34999602</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smucker</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kirby</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Riehl melanosis treated successfully with Q-switch Nd:YAG laser.</article-title>
            <source>J Drugs Dermatol</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>356</fpage>
            <page-range>356-8</page-range>
            <pub-id pub-id-type="pmid">24595582</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chung</surname>
                <given-names>BY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Ko</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>A pilot study of a novel dual--pulsed 1064 nm Q-switched Nd: YAG laser to treat Riehl's melanosis.</article-title>
            <source>J Cosmet Laser Ther</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>16</volume>
            <issue>6</issue>
            <fpage>290</fpage>
            <page-range>290-2</page-range>
            <pub-id pub-id-type="pmid">25046351</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>On</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Roh</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Low-pulse energy Q-switched Nd:YAG laser treatment for hair-dye-induced Riehl's melanosis.</article-title>
            <source>J Cosmet Laser Ther</source>
            <year>2015</year>
            <month>Jun</month>
            <volume>17</volume>
            <issue>3</issue>
            <fpage>135</fpage>
            <page-range>135-8</page-range>
            <pub-id pub-id-type="pmid">25602355</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Roh</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Successful Treatment of Riehl's Melanosis With Mid-Fluence Q-Switched Nd:YAG 1064-nm Laser.</article-title>
            <source>Lasers Surg Med</source>
            <year>2020</year>
            <month>Oct</month>
            <volume>52</volume>
            <issue>8</issue>
            <fpage>753</fpage>
            <page-range>753-760</page-range>
            <pub-id pub-id-type="pmid">31951050</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r53">
          <label>53</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Iwayama</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Oka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Fukumoto</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Treatment of henna-induced Riehl's melanosis with a 755-nm picosecond alexandrite laser.</article-title>
            <source>Lasers Med Sci</source>
            <year>2020</year>
            <month>Sep</month>
            <volume>35</volume>
            <issue>7</issue>
            <fpage>1659</fpage>
            <page-range>1659-1661</page-range>
            <pub-id pub-id-type="pmid">32577930</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r54">
          <label>54</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Hwang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Almurayshid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>MY</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Non-Ablative 1927&#x02009;nm Fractional Thulium Fiber Laser: New, Promising Treatment Modality for Riehl's Melanosis.</article-title>
            <source>Lasers Surg Med</source>
            <year>2021</year>
            <month>Jul</month>
            <volume>53</volume>
            <issue>5</issue>
            <fpage>640</fpage>
            <page-range>640-646</page-range>
            <pub-id pub-id-type="pmid">33259661</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r55">
          <label>55</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Intense pulsed light treatment for inflammatory skin diseases: a review.</article-title>
            <source>Lasers Med Sci</source>
            <year>2022</year>
            <month>Oct</month>
            <volume>37</volume>
            <issue>8</issue>
            <fpage>3085</fpage>
            <page-range>3085-3105</page-range>
            <pub-id pub-id-type="pmid">35913536</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r56">
          <label>56</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Baek</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HY</given-names>
              </name>
            </person-group>
            <article-title>A novel treatment for Riehl's melanosis targeting both dermal melanin and vessels.</article-title>
            <source>Photodermatol Photoimmunol Photomed</source>
            <year>2023</year>
            <month>Nov</month>
            <volume>39</volume>
            <issue>6</issue>
            <fpage>613</fpage>
            <page-range>613-619</page-range>
            <pub-id pub-id-type="pmid">37612856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r57">
          <label>57</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kwon</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Ohn</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Suh</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Choi</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>IH</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>GH</given-names>
              </name>
            </person-group>
            <article-title>A pilot study for triple combination therapy with a low-fluence 1064&#x02009;nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis.</article-title>
            <source>J Dermatolog Treat</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>28</volume>
            <issue>2</issue>
            <fpage>155</fpage>
            <page-range>155-159</page-range>
            <pub-id pub-id-type="pmid">27346606</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r58">
          <label>58</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>CW</given-names>
              </name>
              <name>
                <surname>Jo</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>DH</given-names>
              </name>
              <name>
                <surname>Jo</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mun</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Analysis of Clinical Features and Treatment Outcomes Using 1,064-nm Nd-YAG Laser with Topical Hydroquinone in Patients with Riehl's Melanosis: A Retrospective Study in 10 Patients.</article-title>
            <source>Ann Dermatol</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>127</fpage>
            <page-range>127-132</page-range>
            <pub-id pub-id-type="pmid">33911560</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r59">
          <label>59</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elkamshoushi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Romisy</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Omar</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q-switched Nd:YAG laser for mixed melasma: Clinical and dermoscopic evaluation.</article-title>
            <source>J Cosmet Dermatol</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>21</volume>
            <issue>2</issue>
            <fpage>657</fpage>
            <page-range>657-668</page-range>
            <pub-id pub-id-type="pmid">33826785</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r60">
          <label>60</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Xu</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Xing</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Xiang</surname>
                <given-names>LF</given-names>
              </name>
            </person-group>
            <article-title>Efficacy and safety of the combination of oral tranexamic acid and intense pulsed light versus oral tranexamic acid alone in the treatment of refractory Riehl's melanosis: A prospective, comparative study.</article-title>
            <source>J Cosmet Dermatol</source>
            <year>2024</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>2049</fpage>
            <page-range>2049-2057</page-range>
            <pub-id pub-id-type="pmid">38456556</pub-id>
          </element-citation>
        </ref>
        <ref id="article-28584.r61">
          <label>61</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kumarasinghe</surname>
                <given-names>SPW</given-names>
              </name>
              <name>
                <surname>Pandya</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chandran</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Rodrigues</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dlova</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>HY</given-names>
              </name>
              <name>
                <surname>Ramam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Dayrit</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Goh</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Parsad</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>A global consensus statement on ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, idiopathic eruptive macular pigmentation, and Riehl's melanosis.</article-title>
            <source>Int J Dermatol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>58</volume>
            <issue>3</issue>
            <fpage>263</fpage>
            <page-range>263-272</page-range>
            <pub-id pub-id-type="pmid">30176055</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
